Diagnosis, management, and treatment of vernal keratoconjunctivitis in Asia: Recommendations from the management of vernal keratoconjunctivitis in Asia expert working group

Mehta, Jodhbir S. and Chen, Wei-Li and Cheng, Arthur C. K. and Cung, Le Xuan and Dualan, Ivo J. and Kekunnaya, Ramesh and Khaliddin, Nurliza and Kim, Tae-Im and Lam, Douglas K. and Leo, Seo Wei and Manurung, Florence and Tesavibul, Nattaporn and Bremond-Gignac, Dominique (2022) Diagnosis, management, and treatment of vernal keratoconjunctivitis in Asia: Recommendations from the management of vernal keratoconjunctivitis in Asia expert working group. Frontiers in Medicine, 9. ISSN 2296-858X, DOI https://doi.org/10.3389/fmed.2022.882240.

Full text not available from this repository.

Abstract

Vernal keratoconjunctivitis (VKC) is an underdiagnosed and underrecognized ocular surface disease with limited epidemiological data in Asia. It is more prevalent in warm, dry, and windy climates, and often has a substantial impact on a patient's quality of life. In rare cases, VKC can be associated with vision loss, either through corticosteroid overuse or inadequate treatment of persistent inflammation. As a potentially severe and complex disease, there is variability with how VKC is managed across Asia and among the various allergic eye diseases. Diagnosis and treatment of patients with VKC is a challenge for many ophthalmologists, since no precise diagnostic criteria have been established, the pathogenesis of the disease is unclear, and anti-allergic treatments are often ineffective in patients with moderate or severe disease. In addition, the choice of treatment and management strategies used for patients varies greatly from country to country and physician to physician. This may be because of a lack of well-defined, standardized guidelines. In response, the Management of Vernal Keratoconjunctivitis in Asia (MOVIA) Expert Working Group (13 experts) completed a consensus program to evaluate, review, and develop best-practice recommendations for the assessment, diagnosis, and management of VKC in Asia. The expert-led recommendations are summarized in this article and based on the currently available evidence alongside the clinical expertise of ophthalmologists from across Asia with specialism and interest in the ocular surface, VKC, and pediatric ophthalmology.

Item Type: Article
Funders: Santen Pharmaceutical Asia Pte. Ltd.
Uncontrolled Keywords: Vernal keratoconjunctivitis (VKC); Ocular surface; Ocular allergy; Cyclosporine A (CsA); Corticosteroids; MOVIA; Consensus; Recommendations (guidelines)
Subjects: R Medicine > RE Ophthalmology
Divisions: Faculty of Medicine > Department of Ophthalmology
Depositing User: Ms. Juhaida Abd Rahim
Date Deposited: 22 Nov 2023 09:06
Last Modified: 22 Nov 2023 09:06
URI: http://eprints.um.edu.my/id/eprint/41566

Actions (login required)

View Item View Item